ӰԺ

headshot

Amanda L. Kong, MD, MS, FACS, FSSO, DABS

Professor

Locations

  • Froedtert Hospital
  • Breast Care Center - Cancer Center - Froedtert Hospital
  • Mequon Health Center

Specialties

  • Surgical Oncology

Languages

  • French, English

Cancer Center - Froedtert Hospital

Mequon Health Center

Education

  • MD - Doctor of Medicine
  • MS -Master of Science
  • FACS - Fellow of the American College of Surgeons
  • FSSO-Fellow of the Society of Surgical Oncology
  • DABS - Diplomate of the American Board of Surgery

Biography

Amanda L. Kong, MD, MS, is a professor of surgery and section chief of breast surgery in the Division of Surgical Oncology, Department of Surgery at the ӰԺ. Dr. Kong received her undergraduate degree at Brown University and her MD from the Warren Alpert Medical School of Brown University. She completed her general surgery residency at Mount Sinai Hospital in New York City followed by a Breast Surgical Oncology Fellowship at The University of Texas MD Anderson Cancer Center. She joined the ӰԺ in 2008 as an assistant professor where she obtained a Master’s Degree in Epidemiology in 2010.

Dr. Kong is a member of many prestigious societies including the American Society of Breast Surgeons, the Society of Surgical Oncology, the American Society of Clinical Oncology, and the American College of Surgeons. She currently serves as the Vice Chair of the Breast Fellowship Training Committee of the Society of Surgical Oncology and is the State Chair for Wisconsin for the Commission on Cancer. Dr. Kong is also a member of the Editorial Board of the American Journal of Surgery.

Among her many honors, Dr. Kong has been awarded Best Doctor by M Magazine and Best Doctors in America. She has also been awarded the ӰԺ Outstanding Medical Student Teaching Award several times as well as the Excellence in Professionalism Award from the faculty practice in 2016. Her research focuses on breast cancer disparities and outcomes, breast cancer care in the elderly, as well as improving the quality of life for breast cancer patients. She has published multiple peer reviewed articles and book chapters in addition to being a sought mentor to students and residents.

Clinical Expertise

  • Breast
  • Breast Diseases
  • Breast Neoplasms
  • Carcinoma, Ductal, Breast

Leadership Positions

  • Section Chief, Breast Surgery

Research Interests

Dr. Kong is a breast surgical oncologist with a clinical and research focus in breast cancer and benign breast diseases. She joined the CAPS group (formerly known as PCOR) while completing her Master’s Degree in Epidemiology at the ӰԺ. Her clinical practice provides the foundation for her research to help improve the care of her patients. She has an interest in quality of care and health care disparities with respect to breast cancer outcomes. Her current research focuses on the relationship between hospital volume and breast cancer care, including differences in processes of care in high- and low-volume hospitals and their impact on mortality through the use of large administrative databases and tumor registries. She also has a research focus on the treatment of older breast cancer patients, specifically balancing quality of life and maximizing treatment outcomes.

Publications

  • (Ray HR, Doren EL, Adamson K, Kong AL, Cortina CS.) Am Surg. 2024 Nov;90(11):2769-2779 PMID: 38671547 SCOPUS ID: 2-s2.0-85191696027 04/27/2024

  • (Cortina CS, Kong AL.) JAMA Surg. 2024 Oct 01;159(10):1187 PMID: 39141380 PMCID: PMC11464166 SCOPUS ID: 2-s2.0-85201782322 08/14/2024

  • (Johnson MK, Cortina CS, Aldakkak M, Huang CC, Kong AL.) Clin Breast Cancer. 2024 Oct;24(7):611-619 PMID: 39127597 PMCID: PMC11402566 SCOPUS ID: 2-s2.0-85200951572 08/11/2024

  • (Valencia EA, Cortina CS, Cobb AN, Chaudhary LN, Kelly T, Kong AL.) Ann Surg Open. 2024 Sep;5(3):e465 PMID: 39310356 PMCID: PMC11415127 09/23/2024

  • (Cohen LN, Flanagan C, Kong AL, Cortina CS.) Surg Oncol Insight. 2024 Sep;1(3) PMID: 39130075 PMCID: PMC11310847 08/12/2024

  • (Cortina CS, Kong AL.) Am J Surg. 2024 Aug;234:184-185 PMID: 38423806 PMCID: PMC11223953 SCOPUS ID: 2-s2.0-85188214409 03/01/2024

  • (Cortina CS, Lloren JI, Rogers C, Johnson MK, Cobb AN, Huang CC, Kong AL, Singh P, Teshome M.) Ann Surg Oncol. 2024 May;31(5):3128-3140 PMID: 38270828 PMCID: PMC11003830 SCOPUS ID: 2-s2.0-85183006469 01/25/2024

  • (Jorns JM, Sun Y, Kamaraju S, Cheng YC, Kong A, Yen T, Patten CR, Cortina CS, Chitambar CR, Rui H, Chaudhary LN.) J Pers Med. 2024 Apr 29;14(5) PMID: 38793060 PMCID: PMC11121947 SCOPUS ID: 2-s2.0-85194400127 05/25/2024

  • (Brinton MA, Kong A.) Current Breast Cancer Reports. March 2024;16(1):20-27 SCOPUS ID: 2-s2.0-85182437297 03/01/2024

  • (Rogers C, Cobb AN, Lloren JIC, Chaudhary LN, Johnson MK, Huang CC, Teshome M, Kong AL, Singh P, Cortina CS.) Breast Cancer Res Treat. 2024 Jan;203(2):317-328 PMID: 37864105 PMCID: PMC10872271 SCOPUS ID: 2-s2.0-85174540456 10/21/2023

  • (Chaudhary LN, Jorns JM, Sun Y, Cheng YC, Kamaraju S, Burfeind J, Gonyo MB, Kong AL, Patten C, Yen T, Cortina CS, Carson E, Johnson N, Bergom C, Tsaih SW, Banerjee A, Wang Y, Chervoneva I, Weil E, Chitambar CR, Rui H.) Breast Cancer Res Treat. 2023 Oct;201(3):387-396 PMID: 37460683 PMCID: PMC10795510 SCOPUS ID: 2-s2.0-85164922339 07/18/2023

  • (Johnson MK, Cortina CS, Hsu TL, Huang S, Frebault J, Huang CC, Kong AL.) Ann Surg Oncol. 2023 Oct;30(11):6374-6382 PMID: 37458947 SCOPUS ID: 2-s2.0-85164942787 07/17/2023